Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 2/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.41 |
| ▸ | CEPT1 | Q9Y6K0 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5045844 | 0.87 | ESR1 (0.48) | KDM4ERAB9ANPC1HSD17B10MAPT | |
| SCHEMBL5042036 | 0.87 | KDM4E (0.43) | KDM4ERAB9ANPC1HSD17B10MAPT | |
| SCHEMBL5042047 | 0.81 | TLR7 (0.37) | MAPTSMN1; SMN2POLB | |
| SCHEMBL8577901 | 0.81 | TP53 (0.58) | KDM4ERAB9ANPC1MAPTALDH1A1 | |
| SCHEMBL5044889 | 0.81 | TLR7 (0.43) | MAPTSMN1; SMN2TP53POLB | |
| SCHEMBL5045089 | 0.80 | MEN1 (0.57) | KDM4ERAB9ANPC1HSD17B10MAPT | |
| SCHEMBL5050052 | 0.80 | TLR7 (0.37) | MAPTSMN1; SMN2POLB | |
| SCHEMBL3224035 | 0.79 | MEN1 (0.55) | KDM4ERAB9ANPC1MAPTALDH1A1 | |
| SCHEMBL5041479 | 0.78 | MAPT (0.38) | MAPTSMN1; SMN2POLB | |
| SCHEMBL5049478 | 0.77 | MAPT (0.37) | MAPTSMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7414138-B2 | Benzoxazole and benzodiazole UV-A sunscreens | DSM IP ASSETS B.V. (NL) | 2008-08-19 | — | — | US | claimed |
| US-20050260144-A1 | Benzoxazole and benzodiazole uv-a sunscreens | DSM IP ASSETS B.V. (NL) | 2005-11-24 | — | — | US | claimed |
| EP-1515694-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP Assets B.V. (NL) | 2005-03-23 | — | — | EP | claimed |
| WO-2004000256-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP ASSETS B.V. (NL) | 2003-12-31 | — | — | WO | claimed |
| US-7414138-B2 | Benzoxazole and benzodiazole UV-A sunscreens | DSM IP ASSETS B.V. (NL) | 2008-08-19 | — | — | US | disclosed |
| US-20050260144-A1 | Benzoxazole and benzodiazole uv-a sunscreens | DSM IP ASSETS B.V. (NL) | 2005-11-24 | — | — | US | disclosed |
| EP-1515694-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP Assets B.V. (NL) | 2005-03-23 | — | — | EP | disclosed |
| WO-2004000256-A1 | BENZOXAZOLE AND BENZODIAZOLE UV-A SUNSCREENS | DSM IP ASSETS B.V. (NL) | 2003-12-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050260144-A1 | Benzoxazole and benzodiazole uv-a sunscreens | SUN2, CYP27B1, ERCC4 | KDM4E 1981/4885RAB9A 3057/4885NPC1 919/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.